Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital
| Autor: | Barbara O'Malley, Priya Krishen, Bülent Özgönenel, A.B. Eisenbrey |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Pediatrics Population Hemorrhage Risk Assessment Coagulopathy Humans Medicine heterocyclic compounds cardiovascular diseases education Blood Coagulation Retrospective Studies education.field_of_study Plasma Exchange business.industry Warfarin Anticoagulants Retrospective cohort study Hematology Tertiary care hospital medicine.disease Emergency medicine Population study Fresh frozen plasma business Risk assessment medicine.drug |
| Zdroj: | American Journal of Hematology. 82:1091-1094 |
| ISSN: | 1096-8652 0361-8609 |
| DOI: | 10.1002/ajh.20902 |
| Popis: | Because of the increase in the use of warfarin in the population in recent years, reversal of warfarin-related coagulopathy has become common in daily hospital practice. Transfusion of fresh frozen plasma (FFP) is the preferred treatment method for urgent warfarin reversal in the USA. We have undertaken a 1-month audit of FFP usage to ascertain the impact of warfarin use on the consumption of FFP. Sixty percent of the 376 units of FFP that were transfused during the study month were used to reverse warfarin effects. The most common reason to reverse warfarin was bleeding. Thirty-three percent of the units were used for the treatment of other coagulopathies, 7% were used in therapeutic plasmapheresis, and |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text